Detailed Notes on Oral Contraceptive Pills (OCPs)
History & Exam
Obtain a detailed gynecological history including:
Height, weight, BMI, blood pressure, temperature, pulse, and respiration
Personal gynecologic history: contraceptive methods used? Any problems?
Personal and family history of:
Dyslipidemia
Type 2 Diabetes Mellitus (T2DM)
Hypertension (HTN)
Migraine
Venous thromboembolism (VTE)
Document smoking history.
Pap smear (per ACOG schedule) and STD testing:
Advisable in all patients but not necessary to start OCPs.
Patients under 21 usually won’t need a Pap.
Important to note:
History of premenstrual migraine, acne, dyspareunia.
General Counseling Suggestions
Consider informed consent and disclosure sheet for the patient to sign and provide a copy.
Include:
Information on side effects (SEs) and warning signs (ACHES)
Instructions on managing forgotten pills
Written reinforcement of instructions is crucial, especially for younger patients.
Emphasize contraindicated groups for certain OCPs and inform about drug interactions.
Types of Oral Contraceptive Pills
Combination Pills
Includes:
Extended-Cycle
Triphasic
Progestin-Only Pills
Combined Oral Contraceptives (COCs)
Efficacy
Primary mode of action: Suppression of ovulation.
Additional functions:
Increases viscosity of cervical mucus, thus preventing sperm entry.
Reduces endometrial thickness, lowering ovum implantation risks.
Effectiveness: 91%.
Advantages
Reliable and rapidly reversible.
Health benefits:
Reduced menstrual flow and dysmenorrhea
Improvement in menstrual symptoms and acne
Positive effects on bone mass
Regularity or cessation of menses
Protection against anemia and reduced incidence of:
Ovarian cysts
Endometrial cancer
Colorectal cancer
Other gynecologic diseases causing infertility
Disadvantages
Must remember to take daily.
No STD protection.
Potential decrease in milk production.
Serious complications:
Thrombophlebitis/thromboembolism
Hepatocellular adenomas
Stroke and gallbladder disease
Hypertension
Side Effects
Common:
Nausea, fatigue, acne, mild headaches
Increased appetite, breast fullness/tenderness
Cyclic weight gain and fluid retention
Breakthrough bleeding especially in the first 3 months
Decreased menstrual flow or amenorrhea
Cautions: Cigarette smoking escalates cardiovascular risks.
Dose-Related Side Effects
Too much estrogen:
Nausea, bloating, hypertension
Too little estrogen:
Early/midcycle breakthrough bleeding, increased spotting
Too much progestin:
Increased appetite, weight gain, fatigue, mood changes
Too little progestin:
Late breakthrough bleeding, amenorrhea
Patient Education
Danger Signs (ACHES)
A: Severe abdominal pain (may indicate hepatic tumors or thrombosis)
C: Severe chest pain or shortness of breath (pulmonary embolism, myocardial infarction, angina)
H: Severe headache (potential stroke, migraine or hypertension)
E: Eye problems (blurred vision, flashing lights or blindness; thrombosis)
S: Severe leg pain (potential inflammation or thrombosis in the leg)
General Recommendations
Smoking cessation and maintenance of ideal body weight.
Take the pill at the same time daily.
Follow-Up: Check weight and BP after 3 months on OCP, then annually.
Starting COCs
Start on:
First day of the menstrual cycle
First Sunday of the cycle
Any day of the cycle with backup method for 7 days if starting late.
Missing a pill:
If no intercourse in 5 days prior, take two pills immediately and use backup for 7 days.
If intercourse occurred, offer emergency contraception and use backup for 7 days.
Drug Interactions
Medications that decrease OCP efficacy:
Phenytoin, carbamazepine, rifampin, St. John’s wort, antiretrovirals (especially ritonavir-boosted protease inhibitors).
Contraindications
Absolute Contraindications
Pregnant or <21 days postpartum
Thrombophlebitis/thromboembolic disorders (past or present)
Stroke or coronary artery disease (CAD)
Breast cancer, undiagnosed abnormal vaginal bleeding, or estrogen-dependent cancers
Relative Contraindications
Migraine without aura, hypertension, heart or kidney disease.
Risk Factors for Myocardial Infarction (MI)
Higher risk relates to:
Cigarette smoking, obesity, hypertension, T2DM, hypercholesterolemia.
Women aged >35 who smoke and have other risks should consider non-estrogen birth control methods.
Thromboembolic Disease
Increased rate of VTE in users. Recommend stopping OCPs if:
Developing thromboembolism or at increased risk associated with surgery or fractures.
Cerebrovascular Disease
Slight risk increase for strokes. Stop OCPs if severe headache, visual issues, or transient neurologic disorders occur.
Carcinoma and Hypertension
Minimal risk of breast cancer; reduced risk of several others.
May cause hypertension, particularly in older age and duration of use.
Non-estrogen methods should be used if hypertension arises.
Other Risk Factors
Migraines, especially with aura, contraindicate COC use. Consider alternatives based on personal health considerations (e.g., history of migraines, hypertension).
Progestin-Only Contraception
Mechanism of Action:
Suppresses ovulation, creates atrophic endometrium, thickens cervical mucus.
Available forms include:
Mini-Pill, Medroxyprogesterone Acetate (DMPA), Etonogestrel Implant.
Progestin-Only Pills Efficacy
Similar efficacy to combined OCPs but requires strict adherence (taken within same 3-hour window).
Progestin-Only Advantages and Contraindications
Pros:
Safe for women with estrogen contraindications; ideal for breastfeeding mothers.
Cons include potential irregular bleeding and contraindications related to malabsorptive diseases or past ischemic heart disease.
Patient Education for Progestin-Only Pills
Inform about irregular menstrual bleeding.
Follow-up evaluation after 3 months of use and annual assessments.
Missed Pill Instructions:
If missed for >3 hours, take as soon as possible and use backup for 48 hours.